TX Houston의 소세포 폐암 임상 시험
소세포 폐암 관련 연구 26개가 Houston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
피험자 모집 중2상
- The University of Texas MD Anderson Cancer Center /ID# 277929, Houston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- The University of Texas MD Anderson Cancer Center, Houston
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
피험자 모집 중2/3상
- Texas Oncology - Gulf Coast, Houston
- Texas Oncology - Gulf Coast, Houston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
피험자 모집 중3상
- The University of Texas MD Anderson Cancer Center /ID# 280070, Houston
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
피험자 모집 중1/2상
- Next Oncology - Houston, Houston
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
피험자 모집 중1상
- Oncology Consultants, P.A., Houston
- University of Texas M.D. Anderson Cancer Center, Houston
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- Site 1005, Houston
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
피험자 모집 중1/2상
- Avenzo Therapeutics Recruiting Site, Houston
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
피험자 모집 중3상
- The University of Texas MD Anderson Cancer Center, Houston
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
피험자 모집 중1/2상
- MD Anderson Cancer Center Uni of Te, Houston
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
피험자 모집 중1상
- MD Anderson Cancer Center, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- The University of Texas, MD Anderson Cancer Center, Houston
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
피험자 모집 중3상
- Houston Methodist Cancer Center, Houston
- University of Texas Md Anderson Cancer Center, Houston
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
피험자 모집 중1상
- The University of Texas MD Anderson Cancer Center, Houston
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
피험자 모집 중1/2상
- The University of Texas MD Anderson Cancer Center, Houston
- Oncology Consultants, PA- Houston, Houston
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
피험자 모집 중1상
- University of Texas MD Anderson Cancer Center, Houston
A Study of LY4175408 in Participants With Advanced Cancer
피험자 모집 중1상
- MD Anderson Cancer Center, Houston
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
피험자 모집 중2상
- M D Anderson Cancer Center, Houston
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
피험자 모집 중1/2상
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
피험자 모집 중1/2상
- The University of Texas MD Anderson Cancer Center (site 127), Houston
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
피험자 모집 중1상
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
피험자 모집 중1상
- Zelgen Site 106, Houston
다른 도시의 소세포 폐암 시험
- Arlington, VA연구 23개
- Boston, MA연구 21개
- New York City, NY연구 21개
- Nashville, TN연구 20개
- Los Angeles, CA연구 20개
- Orlando, FL연구 15개
- Dallas, TX연구 13개
- St. Louis, MO연구 13개
- Cleveland, OH연구 13개
- Detroit, MI연구 12개
- Chicago, IL연구 12개
- Washington, DC연구 12개
Houston의 다른 연구
- 비소세포폐암연구 145개
- 유방암연구 126개
- 암 (전체)연구 121개
- 전이성 암연구 104개
- 대장직장암연구 102개
- 난소암연구 89개
- 급성 골수성 백혈병연구 85개
- 폐암연구 78개
- 전립선암연구 76개
- 자궁내막암연구 68개
- 췌장암연구 61개
- 흑색종연구 59개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.